Keith Valentine

Keith C.
Valentine is currently Chief Executive Officer at IsoTis, Inc. and IsoTis OrthoBiologics, Inc. He serves as President & Chief Executive Officer at SeaSpine Orthopedics Corp.
He is President, Chief Executive Officer & Director at Intrinsic Therapeutics, Inc. starting in 2025.
He holds the position of Non-Executive Chairman at Locate Bio Ltd. since 2021.
He is a Director at Reiley Pharmaceuticals, Inc. and StartBox LLC.
He has been an Independent Director at Regentis Biomaterials Ltd. since 2015 and at Alphatec Holdings, Inc. since 2024.
Former roles include President, Chief Executive Officer & Director at Orthofix Medical, Inc. in 2023; President, Chief Executive Officer & Director at SeaSpine, Inc. from 2015 to 2023; President, Chief Executive Officer & Director at SeaSpine Holdings Corp.; President & Chief Executive Officer at Orthofix, Inc. in 2023; Director at California Healthcare Institute; Independent Director at SI-BONE, Inc. from 2015 to 2024; Vice President-Marketing at ORATEC Interventions, Inc. in 2000; President & Chief Operating Officer at NuVasive LLC from 2007 to 2015; Vice President-Thoracolumbar Division Marketing at Medtronic Sofamor Danek, Inc. in 2000; Vice President-Marketing at Medtronic Spine LLC from 1992 to 2000; and Vice President-Marketing at Medtronic, Inc. from 1992 to 2000.
Education includes an undergraduate degree from Western Michigan University conferred in 1990.